96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Compositions and methods for regulating blood pressure
#2402Compositions and methods for regulating arterial tone
#2403Therapeutic agents for reducing parathyroid hormone levels
#2404Homing agents
#2405Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates
#2406Peptides and compositions for prevention of cell adhesion and methods of using same
#2407BK channel-modulating peptides and their use
#2408Synthesis of Beta-Arrestin Effectors
#2409Cytophilic peptide-fused high-density lipoprotein, and delivery of drug to posterior segment of eye by ocular installation of said fusion
#2410Therapeutic targeting of SET1B/compass pathway for treating cancers
#2411Peptide and uses thereof
#2412Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#2413Polypeptides and antibodies for treating HBV infection and related diseases
#2414Peptide for targeting autophagic cells and use thereof
#2415METHODS AND COMPOSITIONS FOR IDENTIFICATION OF HIGHLY SPECIFIC NUCLEASES
#2416CGRP antagonist peptides
#2417Compositions for mitigating hydrogen sulfide contamination using a recombinant protein with an affinity tag fused to a hydrogen sulfide scavenging enzyme
#2418Orally Active, Cell-Penetrating Homing Peptide and Methods of Using Same
#2419Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
#2420Immunotherapy against several tumors including gastrointestinal and gastric cancer
#2421Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
#2422HIGH-SENSITIVE FLUORESCENT ENERGY TRANSFER ASSAY USING FLUORESCENT AMINO ACIDS AND FLUORESCENT PROTEINS
#2423Mirac proteins
#2424CELL PENETRATING PEPTIDES
#2425Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors
#2426Immunotherapy for angiogenic disease
#2427Method and Pharmaceutical Composition for Use in the Treatment of Cancer
#2428S-Alkylated Hepcidin Peptides and Methods of Making and Using Thereof
#2429GPC3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#2430Mu opioid receptor agonist analogs of the endomorphins
#2431Growth Hormone Releasing Peptides
#2432Peptides enhancing neuronal outgrowth and application thereof
#2433DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING
#2434Tumor antigen peptide
#2435Polypeptide and polypeptide complex for suppressing tumor metastasis and treating leukemia as well as preparation method therefor and application thereof
#2436Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#2437Cell penetrating peptides and methods of making and using thereof
#2438Agonists of guanylate cyclase and their uses
#2439Angiotensin-1-receptor antagonists
#2440Synthesis of cell penetrating peptides for drug delivery and stem cell applications
#2441Light-Activated Two-Component Protein Binding Matrix
#2442METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#2443Competitive inhibitors of invariant chain expression and/or ectopic clip binding
#2444Peptide-hinge-free flexible antibody-like molecule
#2445Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#2446METHOD OF MAKING PRODRUGS AND TARGETED THERAPEUTIC COMPOUNDS
#2447Efficient delivery of therapeutic molecules in vitro and in vivo
#2448Compositions for treating pathological calcification conditions, and methods using same
#2449Compositions for treating pathological calcification conditions, and methods using same
#2450SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same
#2451Immunogenic WT-1 peptides and methods of use thereof
#2452Substrates for FLT3 kinase and uses thereof
#2453Approach to treatment of hyperglycemia using a nanoparticle encapsulated peptide
#2454KOC1-derived peptide and vaccine including same
#2455Functionalized titanium binding peptides and implants coated with same
#2456Artificial nucleases comprising engineered cleavage half-domains
#2457Methods for synthesizing α4β7 peptide antagonists
#2458Peptide inhibitors of sodium channels
#2459BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF TUBULYSINS
#2460NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#2461PH-sensitive peptides and their nanoparticles for drug delivery
#2462Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same
#2463Multivalent ligand-lipid constructs
#2464IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC
#2465Inhibitors for inhibiting tumor metastasis
#2466CD8-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#2467PSMA—targeted NIR dyes and their uses
#2468MHC-I restricted epitopes containing non-natural amino acid residues
#2469Manufacture of Degarelix
#2470Vitamin receptor drug delivery conjugates for treating inflammation
#2471Peptides and combination of peptides for use in immunotherapy against various tumors
#2472D-enantiomeric peptides derived from D3 and use thereof
#2473NPR-B agonists
#2474Sequence arrangements and sequences for neoepitope presentation
#2475Immunotherapy against several tumors including gastrointestinal and gastric cancer
#2476Inhibitors of mitochondrial fission and methods of use thereof
#2477Molecular sensor and methods of use thereof
#2478Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
#2479Peptides and combination of peptides for use in immunotherapy against various tumors
#2480NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#2481STATHERIN PEPTIDES
#2482β-sheet breaker peptide used for preventing and/or treating alzheimer's disease
#2483PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE
#2484FAST DISSOLVING PHARMACEUTICAL COMPOSITION
#2485Epitope as a target for therapy of inflammatory autoimmune diseases and graft rejection
#2486METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE
#2487NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
#2488Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
#2489Tumor antigen peptide
#2490Conotoxin polypeptide κ-CPTx-bt104, and method for preparation thereof and application thereof
#2491Peptide derivatives and uses thereof
#2492Immune system modulators
#2493TREATMENT OF IL-17 MEDIATED DISEASE BY BLOCKING SEFIR-SEFIR INTERACTIONS
#2494Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof
#2495Compositions and methods for reducing ice crystal formation
#2496Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#2497Peptides for diagnosis and treatment of cancer
#2498Angiotensin type 2 (AT2) receptor agonists and uses thereof
#2499Crystalline And Amorphous Forms Of A Beta-Arrestin Effector
#2500COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING
#2501Use of inhibitory peptides for the treatment of inflammatory diseases
#2502Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
#2503PSMA-targeted NIR dyes and their uses
#2504FGF-23 epitope peptides and methods of use thereof
#2505Peptidomimetic macrocycles
#2506LINEAR PEPTIDE ANTIBIOTICS
#2507NOVEL PEPTIDE COMPOSITIONS
#2508PEPTIDES FOR SUPPRESSING INFLAMMATION
#2509Peptide having activity to improve skin condition and use thereof
#2510Opioid peptide
#2511Method for regressing pancreatic tumor by a liposomal formulation along with DNA vaccines
#2512Microwave-assisted peptide synthesis
#2513Methods of treating cancer using compounds containing a vascular disrupting agent
#2514TARGETED ANTIMICROBIAL MOIETIES
#2515Neurodegenerative disorders
#2516CARCINOMA HOMING PEPTIDE (CHP), ITS ANALOGS, AND METHODS OF USING
#2517POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF
#2518ALZHEIMER'S DISEASE TREATMENT METHOD
#2519Peptide having osteoclast differentiation and activation inhibition, and use of same
#2520TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#2521Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#2522Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#2523Quantification of vaccine compositions
#2524Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#2525Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#2526Hexapeptide for neuroprotection against a β toxicity
#2527Method for efficient delivery of therapeutic molecules in vitro and in vivo
#2528Norovirus antibodies
#2529STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#2530EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) PEPTIDES AND BINDING ANTIBODIES
#2531Desmoglein 2 (DSG2) binding proteins and uses therefor
#2532Anti-microbial peptides
#2533TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
#2534Peptide having osteoblast proliferation activity and periodontal ligament fibroblast proliferation activity, and use of same
#2535ALDEHYDE CAPTURE LIGATION TECHNOLOGY FOR SYNTHESIS OF AMIDE BONDS
#2536Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer
#2537Immunostimulatory method
#2538Selective recovery
#2539Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the same
#2540Melanocortin receptor ligands
#2541Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism
#2542Methods and compositions related to inhibition of viral entry
#2543Synthetic peptide and use thereof
#2544Cancer vaccine composition
#2545Telomerase polypeptide vaccine for treating cancer
#2546Telomerase polypeptide vaccine for treating cancer
#2547Opioid peptide
#2548Methods and compositions for stimulating collagen synthesis in skin cells
#2549Markers for mood disorders
#2550Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#2551METHOD FOR PRODUCING HYDROPHOBIC PEPTIDE
#2552Smart Pro-Drugs of Serine Protease Inhibitors
#2553Multifunctional protein molecular weight ladders
#2554Functional lipid constructs
#2555Bouvardin derivatives and therapeutic uses thereof
#2556SYNTHETIC ANALOGUES OF NEURAL REGENERATION PEPTIDES
#2557Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#2558Peptide compounds for inhibitions of platelet aggregation
#2559Peptide for inducing multinucleation in cells, and use therefor
#2560Cyclin based inhibitors of CDK2 and CDK4
#2561Melanocortin 1 receptor ligands and methods of use
#2562Selected reaction monitoring assays
#2563Antibody-binding polypeptide, antibody-binding fusion polypeptide, and adsorption material
#2564Antimicrobial compositions and method of use thereof
#2565Peptide inhibitors of serotonin 5-HTreceptor:PTEN interaction
#2566Methods and compositions for treating pain
#2567Methods and compounds to suppress viral genome release and packaging
#2568Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
#2569Selective recovery
#2570Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#2571Antibacterial agents
#2572CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF
#2573TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME
#2574KIF20A epitope peptides for TH1 cells and vaccines containing the same
#2575Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#2576Cell penetrating peptides and methods of making and using thereof
#2577Beta sheet tapes ribbons in tissue engineering
#2578Method for preparing AMG 416
#2579Emetine Derivatives, Prodrugs Containing Same, And Methods Of Treating Conditions Using Same
#2580Peptides and combination of peptides for use in immunotherapy against various cancers
#2581Peptides and combination of peptides for use in immunotherapy against various cancers
#2582Peptides and combination of peptides for use in immunotherapy against various cancers
#2583Peptides and combination of peptides for use in immunotherapy against various cancers
#2584Peptides and combination of peptides for use in immunotherapy against various cancers
#2585Peptides and combination of peptides for use in immunotherapy against various cancers
#2586Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#2587Cancer targeting by anti-EGFR peptides and applications thereof
#2588Drug delivery enhancement agents
#2589Use of a tetraphenylborate (TPB) salt for the separation of biomolecules
#2590Composition for delivery of genetic material
#2591Biologically active peptides
#2592Bi-terminal pegylated integrin-binding peptides and methods of use thereof
#2593LLP2A-bisphosphonate conjugates for osteoporosis treatment
#2594Bladder cancer specific ligand peptides
#2595Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
#2596Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#2597Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2598Isolated donor MHC-derived peptide and uses thereof
#2599Method for treating blood, blood products and organs
#2600Targeting peptides for directing adeno-associated viruses (AAVs)
#2601Precipitable peptides
#2602Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2603Peptides and combination of peptides for use in immunotherapy against various cancers
#2604Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2605Targeting of PELP1 in cancer therapy
#2606Method for inhibiting intracellular activated RAS using intact immunoglobulin-type antibody having cytosol-penetrating ability and use thereof
#2607Peptides and combination of peptides for use in immunotherapy against various tumors
#2608Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#2609Cancer stem cell targeting peptide and use thereof
#2610Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics
#2611METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE
#2612Use of endostatin peptides for the treatment of fibrosis
#2613SYSTEM AND METHOD FOR IDENTIFICATION OF PROTEASE SUBSTRATES
#2614NPP1 FUSION PROTEINS
#2615Peptides and combination of peptides for use in immunotherapy against various tumors
#2616Peptides and combination of peptides for use in immunotherapy against various tumors
#2617Melanocortin-1 receptor-specific linear peptides
#2618PEPTIDE INHIBITORS OF CASPASE 2 ACTIVATION
#2619Vault complexes for cytokine delivery
#2620Peptide as absorption enhancer and composition containing same
#2621Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#2622Antimicrobial peptide dendrimers
#2623Modulation of complement activity
#2624Epitope tag and method for detection and/or purification of tagged polypeptides
#2625Peptide-induced NK cell activation
#2626C6S specific transporter molecules
#2627Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides
#2628NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#2629Antibody molecule-drug conjugates and uses thereof
#2630Peptides with antimicrobial, anticancer and/or wound-healing promoting activities, pharmaceutical compositions containing the same, and use of the peptides with antimicrobial, anticancer and/or wound-healing promoting activities
#2631GrB-EHinhibitory peptides
#2632Affinity peptide ligand of mouse polyoma virus capsomer and designed screening method thereof
#2633Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands
#2634Dereplication strain of
#2635Acceleration of growth
#2636Ganirelix precursor and method for preparing ganirelix acetate by using the same
#2637Inhibitors of metastasis
#2638NOVEL COMPOUNDS COMPRISING A BOMBESIN DERIVATIVE, A PROCESS FOR THE PREPARATION THEREOF AND A NUCLEAR MOLECULAR IMAGING AGENT COMPRISING THE SAME
#2639Fluorescent imaging agents
#2640Chloride salt of TAT-NR2B9c
#2641TARGETING DIMERIZATION OF BAX TO MODULATE BAX ACTIVITY
#2642THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#2643Keratan sulfate specific transporter molecules
#2644Methods of Treatment and Prevention of Disease by Arginine-rich Compositions that Induce Cytoprotection and Neuroprotection
#2645Antagonists for abdominal vasopressin V2 receptor and uses thereof
#2646Template-fixed peptidomimetics with antimicrobial activity
#2647Method for inhibiting ADAM proteases with cyclic peptides
#2648Neuroprotective composition and method of use
#2649Peptidomimetic macrocycles as modulators of MCL-1
#2650ACTH prophylactic treatment of renal disorders
#2651Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing peptides
#2652Chemical and biochemical adducts as biomarkers for organophosphate exposure
#2653Methods of treating ophthalmic diseases using NPR-B agonists
#2654Covalent tethering of functional groups to proteins and substrates therefor
#2655Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#2656Tumor-targeting compounds
#2657INHIBITION OF GLIADIN PEPTIDES
#2658USE OF PEPTIDIC DRUGS FOR OSTEOPOROSIS TREATMENT AND BONE REGENERATION
#2659Macrocyclic broad spectrum antibiotics
#2660Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
#2661Modular antigen transportation molecules and uses thereof in animals
#2662Near-infrared light-activated proteins
#2663Anti-PVRIG antibodies and methods of use
#2664Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
#2665RTEF-1 variants and the use thereof for inhibition of angiogenesis
#2666Antimicrobial peptides and their application
#2667SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS
#2668Methods and systems for solid phase peptide synthesis
#2669Stabilizied bioactive peptides and methods of identification, synthesis and use
#2670Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same
#2671Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
#2672Anti-lymphoma peptides
#2673ANTIMICROBIAL PEPTIDES
#2674Broad spectrum antibiotics
#2675METHODS FOR THE TREATMENT OF X-LINKED HYPOPHOSPHATEMIA AND RELATED DISORDERS
#2676Mesothelin vaccines and model systems
#2677Xenoantigen-displaying anti-cancer vaccines and method of making
#2678Stitched polypeptides
#2679PSMA-targeted NIR dyes and their uses
#2680PSMA-targeted NIR dyes and their uses
#2681γ-AApeptides with potent and broad-spectrum antimicrobial activity
#2682Composition for organ, tissue, or cell transplantation, kit, and transplantation method
#2683Bioactive peptide complexes
#2684Cell penetrating peptide and method for delivering biologically active substance using same
#2685Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
#2686Method for treating cancer with activated T cells
#2687Peptides of syndecan-1 for inhibiting angiogenesis
#2688JNK inhibitor molecules for treatment of various diseases
#2689IL-17F-specific capture agents, compositions, and methods of using and making
#2690Methods of developing selective peptide antagonists
#2691Peptide having efficacy for remedying hypopigmentation and inhibiting adipogenesis, and use of same
#2692HEPCIDIN MIMETIC PEPTIDES AND USES THEREOF
#2693Inhibitors of NF κ-B activity for treatment of diseases and disorders
#2694DOTAM DERIVATIVES FOR THERAPEUTIC USE
#2695Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same
#2696Mirac proteins
#2697Integrin Antagonists
#2698Method for identifying novel minor histocompatibility antigens
#2699COMPOUND FOR TREATING SEQUELAE OF ISCHEMIC CEREBRAL STROKE
#2700COMPOSITIONS COMPRISING GLUTEN PEPTIDES AND USES THEREOF